Transtorno relacionado ao uso de esteroides anabolizantes

Referências

Principais artigos

Chyka PA. Androgenic-anabolic steroids. In: Ford MD, Delaney KA, Ling LJ, et al, eds. Clinical toxicology. New York, NY: WB Saunders; 2001:595-601.

Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-54. Resumo

Dhar R, Stout CW, Link MS, et al. Cardiovascular toxicities of performance-enhancing substances in sports. Mayo Clin Proc. 2005 Oct;80(10):1307-15.Texto completo  Resumo

National Institute on Drug Abuse. Research report series: anabolic steroid abuse. NIH Publication 06-3721. August 2006 [internet publication].Texto completo

Brower KJ. Anabolic steroid abuse and dependence. Curr Psychiatry Rep. 2002 Oct;4(5):377-87. Resumo

Artigos de referência

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.

2. Catlin DH, Hatton CK. Use and abuse of anabolic and other drugs for athletic enhancement. Adv Intern Med. 1991 Jan 1;36:399-424. Resumo

3. Prendergast HM, Bannen T, Erickson TB, et al. The toxic torch of the modern Olympic Games. Vet Hum Toxicol. 2003 Mar;45(2):97-102. Resumo

4. Catlin DH, Kammerer RC, Hatton CK, et al. Analytical chemistry at the Games of the XXIIIrd Olympiad in Los Angeles, 1984. Clin Chem. 1987 Feb;33(2 Pt 1):319-27. Resumo

5. Kutscher EC, Lund BC, Perry PJ. Anabolic steroids: a review for the clinician. Sports Med. 2002;32(5):285-96. Resumo

6. Yesalis CE 3rd, Herrick RT, Buckley WE, et al. Self-reported use of anabolic-androgenic steroids by elite power lifters. Phys Sportsmed. 1988 Dec;16(12):91-100.

7. Dezelsky TL, Toohey JV, Shaw RS. Non-medical drug use behaviour at five United States universities: a 15-year study. Bull Narc. 1985 Apr-Sep;37(2-3):49-53. Resumo

8. Chyka PA. Androgenic-anabolic steroids. In: Ford MD, Delaney KA, Ling LJ, et al, eds. Clinical toxicology. New York, NY: WB Saunders; 2001:595-601.

9. Korkia P, Stimson GV. Indications of prevalence, practice and effects of anabolic steroid abuse in Great Britain. Int J Sports Med. 1997 Oct;18(7):557-62. Resumo

10. Tahtamouni LH, Mustafa NH, Alfaouri AA, et al. Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes. Eur J Public Health. 2008 Dec;18(6):661-5. Resumo

11. Rachoń D, Pokrywka L, Suchecka-Rachoń K. Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz Praventivmed. 2006;51(6):392-8. Resumo

12. Johnston LD, O'Malley PM, Bachman JG, et al; University of Michigan News Service: Ann Arbor, MI. Teen marijuana use tilts up, while some drugs decline in use. December 2009 [internet publication].Texto completo

13. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the future: national results on adolescent drug use. Overview of key findings, 2011. Ann Arbor, MI: University of Michigan Institute for Social Research; 2012.Texto completo

14. NIDA for Teens. Anabolic steroids. May 2015 [internet publication].Texto completo

15. Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance: United States, 2005. MMWR Surveill Summ. 2006 Jun 9;55(5):1-108.Texto completo  Resumo

16. Centers for Disease Control and Prevention. Youth Risk Behavior Surveillance - United States, 2011. MMWR Surveill Summ. 2012 Jun 8;61(4):1-162.Texto completo  Resumo

17. Kanayama G, Boynes M, Hudson JI, et al. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 2007 May 11;88(2-3):156-62.Texto completo  Resumo

18. US Drug Enforcement Administration, Office of Diversion Control. Anabolic steroids: hidden dangers. March 2004 [internet publication].Texto completo

19. Buckley WE, Yesalis CE 3rd, Friedl KE, et al. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988 Dec 16;260(23):3441-5. Resumo

20. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008 Jun;154(3):502-21.Texto completo  Resumo

21. Petersson A, Bengtsson J, Voltaire-Carlsson A, et al. Substance abusers’ motives for using anabolic androgenic steroids. Drug Alcohol Depend. 2010 Sep 1;111(1-2):170-2. Resumo

22. Hakansson A, Mickelsson K, Wallin C, et al. Anabolic androgenic steroids in the general population: user characteristics and associations with substance use. Eur Addict Res. 2012;18(2):83-90.Texto completo  Resumo

23. Lindqvist AS, Moberg T, Eriksson BO, et al. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health. Br J Sports Med. 2013 Oct;47(15):965-9. Resumo

24. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-54. Resumo

25. Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008 Nov 1;98(1-2):1-12. Resumo

26. Dhar R, Stout CW, Link MS, et al. Cardiovascular toxicities of performance-enhancing substances in sports. Mayo Clin Proc. 2005 Oct;80(10):1307-15.Texto completo  Resumo

27. Maior AS, Carvalho AR, Marques-Neto SR, et al. Cardiac autonomic dysfunction in anabolic steroid users. Scand J Med Sci Sports. 2013 Oct;23(5):548-55. Resumo

28. Blashill AJ, Safren SA. Sexual orientation and anabolic-androgenic steroids in U.S. adolescent boys. Pediatrics. 2014 Mar;133(3):469-75. Resumo

29. Pope HG Jr, Phillips KA, Olivardia R. The Adonis complex: the secret crisis of male body obsession. New York, NY: Free Press; 2000.

30. Leone JE, Sedory EJ, Gray KA. Recognition and treatment of muscle dysmorphia and related body image disorders. J Athl Train. 2005 Oct-Dec;40(4):352-9.Texto completo  Resumo

31. National Institute on Drug Abuse. Research report series: anabolic steroid abuse. NIH Publication 06-3721. August 2006 [internet publication].Texto completo

32. Pope HG Jr, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000 Feb;57(2):133-40.Texto completo  Resumo

33. Su TP, Pagliaro M, Schmidt PJ, et al. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 1993 Jun 2;269(21):2760-4. Resumo

34. Yates WR, Perry PJ, MacIndoe J, et al. Psychosexual effects of three doses of testosterone cycling in normal men. Biol Psychiatry. 1999 Feb 1;45(3):254-60. Resumo

35. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996 Jul 4;335(1):1-7.Texto completo  Resumo

36. O'Connor DB, Archer J, Hair WM, et al. Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men. Physiol Behav. 2002 Apr 1;75(4):557-66. Resumo

37. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1172-81. Resumo

38. Pope HG Jr, Katz D. Psychiatric effects of anabolic steroids. Psychiatr Ann. 1992;22:24-9.

39. Clark AS, Henderson LP. Behavioral and physiological responses to anabolic-androgenic steroids. Neurosci Behav Rev. 2003 Aug;27(5):413-36. Resumo

40. Hall RC, Hall RC, Chapman MJ. Psychiatric complications of anabolic steroid abuse. Psychosomatics. 2005 Jul-Aug;46(4):285-90. Resumo

41. Thevis M, Kuuranne T, Geyer H, et al. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal. 2011 Jan;3(1):1-14. Resumo

42. Golestani R, Slart RH, Dullaart RP, et al. Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging. Eur J Clin Invest. 2012 Jul;42(7):795-803.Texto completo  Resumo

43. Brower KJ. Anabolic steroid abuse and dependence. Curr Psychiatry Rep. 2002 Oct;4(5):377-87. Resumo

44. Brower KJ. Clinical assessment and treatment of anabolic steroid users. Psychiatr Ann. 1992;22(1):35-40.

45. Dickerman RD, Pertusi RM, Zachariah NY, et al. Anabolic steroid-induced hepatotoxicity: is it overstated? Clin J Sport Med. 1999 Jan;9(1):34-9. Resumo

46. Basaria S. Androgen abuse in athletes: detection and consequences. J Clin Endocrinol Metab. 2010 Apr;95(4):1533-43. Resumo

47. Abushareeda W, Fragkaki A, Vonaparti A, et al. Advances in the detection of designer steroids in anti-doping. Bioanalysis. 2014 Mar;6(6):881-96. Resumo

48. Kanayama G, Brower KJ, Wood RI, et al. Treatment of anabolic-androgenic steroid dependence: emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun 1;109(1-3):6-13.Texto completo  Resumo

49. National Institute for Health and Care Excellence. Needle and syringe programmes. March 2014 [internet publication]Texto completo

50. Wood RI. Anabolic-androgenic steroid dependence? Insights from animals and humans. Front Neuroendocrinol. 2008 Oct;29(4):490-506. Resumo

51. Peters KD, Wood RI. Androgen dependence in hamsters: overdose, tolerance, and potential opioidergic mechanisms. Neuroscience. 2005;130(4):971-81. Resumo

52. Far HR, Ågren G, Thiblin I. Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings. Cardiovasc Pathol. 2012 Jul-Aug;21(4):312-6. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal